title: Rapid progression of unilateral moyamoya disease in a patient with a family history and an RNF213 risk variant.
authors.affiliation: Division of Neuroendovascular Therapy, Institute of Biomedical Research and Innovation, Kobe, Japan.
authors.forename: Yohei
authors.initials: Y
authors.lastname: Mineharu
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Takagi
authors.forename: Jun C
authors.initials: JC
authors.lastname: Takahashi
authors.forename: Hirokuni
authors.initials: H
authors.lastname: Hashikata
authors.forename: Wanyang
authors.initials: W
authors.lastname: Liu
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Hitomi
authors.forename: Hatasu
authors.initials: H
authors.lastname: Kobayashi
authors.forename: Akio
authors.initials: A
authors.lastname: Koizumi
authors.forename: Susumu
authors.initials: S
authors.lastname: Miyamoto
mesh_terms: D000251:Adenosine Triphosphatases; D000328:Adult; D018450:Disease Progression; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D009072:Moyamoya Disease / Q000175:diagnosis / Q000235:genetics*; D009154:Mutation / Q000235:genetics*; D010375:Pedigree; D044767:Ubiquitin-Protein Ligases / Q000235:genetics*
chemical_list: C557998:RNF213 protein, human; D044767:Ubiquitin-Protein Ligases; D000251:Adenosine Triphosphatases